Basu A, Chakrabarti G, Saha A, Bandyopadhyay S
Indian Institute of Chemical Biology, Calcutta, India.
Immunology. 2000 Feb;99(2):305-13. doi: 10.1046/j.1365-2567.2000.00939.x.
BALB/c mice resolve Leishmania donovani infection in the liver over an 8-12-week period. However, after an initial phase of 2-4 weeks where increases in parasite load are not readily detectable, parasite numbers in the spleen begin to increase reaching maximum levels at 16 weeks post-infection. Thereafter, parasite replication in the spleen is controlled and BALB/c mice maintain this residual parasite load in the spleen for many months, without further increase. We evaluated functions of CD11C+ splenic dendritic cells throughout the course of L. donovani infection in the spleen of BALB/c mice. Unlike the dendritic cell (DC)-specific antigen DEC-205, CD11C was not up-regulated on macrophages during visceral leishmaniasis. No appreciable impairment of splenic DC functions was observed when this antigen-presenting cell subset was purified from 30-day post-infected mice. Significant impairment in inducing allogeneic mixed lymphocyte reaction (MLR) and presenting L. donovani antigens or keyhole limpet haemocyanin (KLH) to specific T cells was observed with CD11C+ splenic DC purified from 60-day post-infected mice. Functional impairment of splenic DC at 60 days post-infection correlated with their reduced surface expression of major histocompatibility complex (MHC) class II molecules, impairment of interleukin-12 (IL-12) production and to their ability to suppress interferon-gamma (IFN-gamma) production by Leishmania antigen-primed T cells. Of interest, the impairment of splenic DC in presenting Leishmania antigens or KLH to specific T cells was corrected at 120 days post-infection, and correlated with their up-regulation of MHC class II expression, IL-12 production, induction of IFN-gamma by Leishmania antigen-primed T cells and the onset of control over splenic parasite replication in vivo. These results indicate that functional integrity of DC may be important in controlling L. donovani infection.
BALB/c小鼠在8 - 12周内清除肝脏中的杜氏利什曼原虫感染。然而,在最初2 - 4周寄生虫负荷增加不易检测到的阶段之后,脾脏中的寄生虫数量开始增加,在感染后16周达到最高水平。此后,脾脏中的寄生虫复制得到控制,BALB/c小鼠在脾脏中维持这种残余寄生虫负荷数月,不再进一步增加。我们评估了BALB/c小鼠脾脏中杜氏利什曼原虫感染全过程中CD11C⁺脾树突状细胞的功能。与树突状细胞(DC)特异性抗原DEC - 205不同,在内脏利什曼病期间巨噬细胞上CD11C未上调。当从感染后30天的小鼠中纯化该抗原呈递细胞亚群时,未观察到脾DC功能有明显损害。从感染后60天的小鼠中纯化的CD11C⁺脾DC在诱导同种异体混合淋巴细胞反应(MLR)以及向特异性T细胞呈递杜氏利什曼原虫抗原或钥孔戚血蓝蛋白(KLH)方面观察到显著损害。感染后60天脾DC的功能损害与其主要组织相容性复合体(MHC)II类分子表面表达降低、白细胞介素 - 12(IL - 12)产生受损以及抑制利什曼原虫抗原致敏T细胞产生干扰素 - γ(IFN - γ)的能力有关。有趣的是,感染后120天脾DC在向特异性T细胞呈递利什曼原虫抗原或KLH方面的损害得到纠正,这与其MHC II类表达上调、IL - 12产生、利什曼原虫抗原致敏T细胞诱导IFN - γ以及体内脾脏寄生虫复制控制的开始相关。这些结果表明DC的功能完整性在控制杜氏利什曼原虫感染中可能很重要。